Deep learning models based on CT predict prognosis in patients with locally advanced esophageal squamous cell carcinoma who received neoadjuvant immunotherapy and chemotherapy
ObjectiveNeoadjuvant immunotherapy and chemotherapy (NICT) has emerged as the standard pharmacological intervention for locally advanced esophageal squamous cell carcinoma (ESCC). However, individual responses to this drug combination vary significantl…